Best Peptides for Gut Research: BPC-157, KPV, VIP and More

The gut is one of the busiest and most demanding places in the body. Its inner lining is replaced every few days, it holds back trillions of bacteria while absorbing everything we eat, it contains more immune cells than the rest of the body put together, and it has so many nerve cells of its own that scientists call it the second brain. Keeping all of that in balance depends heavily on peptides, and some of the most studied research peptides have their roots, quite literally, in the gut.

This guide explains the main peptides used in gastrointestinal research in plain English, what the key studies found and how each is thought to work, organised so you can match the right compound to the right research question. Every compound mentioned is supplied by Crown Peptides for laboratory research use only.

Why the Gut Is Such a Rich Area for Peptide Research

A barrier that renews itself constantly

The gut lining is a single layer of cells, sealed together by structures called tight junctions, that separates the contents of the gut from the body. It is renewed every few days from stem cells in the depths of the gut wall. When that barrier is damaged, by inflammation, injury or chemical stress, repair has to be fast. Research on how the lining heals, and how inflammation disrupts it, is central to gut biology.

The gut makes its own peptides

The gut is one of the body’s largest hormone-producing organs. It makes ghrelin, the hunger signal; GLP-1, the fullness signal; VIP, a regulator of movement and secretion; and many more. It also absorbs short peptides from digested food using a dedicated transporter, PepT1, which, as we will see, some research peptides use too.

Inflammation at the centre

Inflammatory bowel conditions, in which the gut lining is persistently inflamed, are a major focus of gut research. Many research peptides are studied for their ability to calm inflammatory signalling or speed repair of the lining in animal models of colitis.

A Tour of the Gut

It helps to know the territory. The gut is a continuous tube of very different regions, each with its own job and its own research questions.

The stomach

The stomach holds and churns food in strong acid, which kills many microbes and starts protein digestion. Its lining protects itself with a thick layer of mucus and bicarbonate. Gastric ulcers form when that protection fails. The stomach is also the main source of ghrelin, and of the gastric juice protein from which BPC-157 was derived.

The small intestine

The small intestine, around six metres long, is where most nutrients are absorbed. Its lining is folded into millions of finger-like villi, covered in cells with their own microscopic projections, giving it an enormous surface area. Between the villi sit crypts, where stem cells continuously produce new lining cells. PepT1, the peptide transporter, is most abundant here.

The colon

The colon absorbs water and salts and houses the densest population of gut bacteria. It is the main site of inflammation in ulcerative colitis, and the target of most of the colitis models used in gut peptide research.

A Short History of Gut Peptides

The gut has a special place in the history of peptide science. In 1902, the British physiologists William Bayliss and Ernest Starling discovered that the gut lining releases a substance into the blood that tells the pancreas to secrete digestive juice. They called it secretin, and it was the first hormone ever discovered. Starling coined the word “hormone” shortly afterwards. Secretin is a peptide.

Gastrin, which stimulates stomach acid, followed, and in 1970 Sami Said and Viktor Mutt isolated vasoactive intestinal peptide from the gut, discovering one of the most versatile regulatory peptides known. The discovery of ghrelin in the stomach in 1999 and the rise of GLP-1 medicines in the 2000s and 2010s confirmed the gut as one of the body’s great peptide factories. BPC-157 and KPV continue that tradition in research.

BPC-157: Born in Gastric Juice

BPC-157 is a 15-amino-acid peptide derived from a protein found in human gastric juice, studied for decades by Predrag Sikirić’s group at the University of Zagreb. It is often described as the stable gastric pentadecapeptide because, unusually, it survives the acidic environment of the stomach.

What the research shows

BPC-157’s research began in the gut and has spread from there. A 2021 review in Frontiers in Pharmacology by Seiwerth, Sikirić and colleagues described healing research across many tissues in animal models, including the gastrointestinal tract, and noted that BPC-157 rapidly increases the expression of various genes in wound models (PMID: 34267654, PMC8275860). Its gastrointestinal research includes models of ulcers, fistulas and inflammation of the bowel.

Research has also indicated that BPC-157 may support blood vessel growth, a key part of repairing damaged tissue. A 2017 study in the Journal of Molecular Medicine found it increased blood vessel formation and activated the VEGFR2 signalling pathway (PMID: 27847966).

A regulatory milestone

In July 2026, a US FDA advisory committee voted to recommend adding BPC-157 to the list of substances US compounding pharmacies may use, having reviewed it for ulcerative colitis, a sign of how central the gut is to its research profile. Our article on the FDA advisory panel vote explains what that means.

Best suited to

Research on repair of the gut lining, ulcer and fistula models, and blood vessel growth in damaged tissue. See our BPC-157 guide.

KPV: Riding the Gut’s Own Transporter

KPV is a three-amino-acid peptide, lysine-proline-valine, that forms the tail end of the hormone alpha-MSH. Research has indicated it carries much of that hormone’s anti-inflammatory activity without its effect on pigmentation.

What the research shows

The landmark study came in 2008 from Emory University. In Gastroenterology, Dalmasso, Merlin and colleagues showed that nanomolar concentrations of KPV inhibited NF-kappaB and MAP kinase inflammatory signalling in human intestinal cells and immune cells, that KPV enters cells through PepT1, the gut’s own peptide transporter, and that KPV in drinking water reduced inflammation in two mouse models of colitis (PMID: 18061177, PMC2431115). PepT1 becomes more active in the inflamed colon, which makes it a particularly neat route.

Later work focused on delivery. In a 2017 study in Molecular Therapy, the same group loaded KPV into hyaluronic acid-coated nanoparticles that targeted colon lining cells and macrophages, and found they both sped healing of the gut lining and reduced inflammation in mice (PMID: 28143741, PMC5498804). In 2022, a team in Wenzhou designed a hydrogel that sticks specifically to inflamed colon lining and showed that KPV delivered this way helped restore the gut barrier and increased beneficial gut bacteria in rats (PMID: 35245681).

Best suited to

Research on intestinal inflammation, NF-kappaB signalling, gut barrier repair and targeted peptide delivery. See our KPV guide.

VIP: The Gut’s Own Regulator

VIP, vasoactive intestinal peptide, is a 28-amino-acid neuropeptide that was first isolated from the gut, hence its name. It is released by nerves in the gut wall and by immune cells, and it relaxes smooth muscle, stimulates secretion of water and electrolytes, and regulates blood flow.

What the research shows

VIP is also a powerful immune regulator. A 2013 review in Amino Acids by Delgado and Ganea described VIP’s pleiotropic immune functions, its receptors on immune cells, and its involvement in inflammatory and autoimmune conditions (PMID: 22139413, PMC3883350). That dual role, gut function and immune calming, makes it a natural gut research tool.

Best suited to

Research on gut motility and secretion, the enteric nervous system and immune regulation in the gut. See VIP: the peptide with a hand in almost every organ system.

Ghrelin Receptor Agonists: Getting the Gut Moving

Ghrelin, the hunger hormone, is made in the stomach and also stimulates gut movement. Research peptides that act on the ghrelin receptor have therefore been studied in gut motility.

Ipamorelin and postoperative ileus

After abdominal surgery, the bowel often stops moving for a time, a condition called postoperative ileus. In a 2009 study in the Journal of Pharmacology and Experimental Therapeutics, Ipamorelin shortened the time to first bowel movement after surgery in rats, and repeated dosing increased faecal output, food intake and body weight gain; GHRP-6 was used as a comparison compound (PMID: 19289567). A 2014 phase 2 trial in 117 bowel resection patients found Ipamorelin well tolerated; the median time to first tolerated meal was 25.3 hours versus 32.6 hours with placebo, a difference that did not reach statistical significance in that small study (PMID: 25331030).

Best suited to

Research on gut motility and the ghrelin system. See our Ipamorelin guide.

Other Compounds With a Gut Research Angle

TB-500

TB-500, based on thymosin beta-4, is studied mainly for cell migration and tissue repair, processes that also matter in healing the gut lining. It pairs with BPC-157 in the Wolverine Stack (BPC-157 + TB-500 Blend).

LL-37

LL-37, the body’s own cathelicidin antimicrobial peptide, is part of the gut lining’s chemical defence against bacteria. See LL-37 vs KPV.

Glutathione

Glutathione is abundant in the gut lining, where it protects cells from oxidative damage caused by inflammation and dietary chemicals.

KLOW

KLOW combines BPC-157, TB-500, GHK-Cu and KPV in one vial, covering repair and inflammation together. See our KLOW blend guide.

The Gastrointestinal Research Bundle

For researchers studying the gut as a system, Crown Peptides offers the Gastrointestinal Research Bundle, which brings together BPC-157, KPV and VIP in separate vials. The three cover complementary angles: tissue repair and blood vessel growth, inflammatory signalling through the gut’s own transporter, and the gut’s native regulator of movement, secretion and immunity. Our article three peptides, one gut axis explains the rationale.

The Gut-Brain Axis

The gut and the brain are in constant conversation through the vagus nerve, through hormones and through immune signals. The gut’s own nervous system, the enteric nervous system, contains hundreds of millions of neurons and can run digestion largely by itself. Many gut peptides, including VIP and ghrelin, also act in the brain. That two-way link is why gut research increasingly overlaps with brain research, and why compounds such as VIP are studied in both. Our brain research guide covers the other end of the axis.

The Microbiome and the Gut’s Chemical Defences

The gut lining does not simply block bacteria; it actively manages them. Specialised cells deep in the small intestine’s crypts, called Paneth cells, release antimicrobial peptides such as defensins, and the lining also produces cathelicidins such as LL-37. These peptides help keep bacteria at a safe distance from the lining while allowing beneficial species to thrive. When that balance is disturbed, inflammation can follow. The 2022 KPV hydrogel study, which found increased beneficial bacteria after treatment, is an example of how gut peptide research increasingly measures the microbiome alongside inflammation.

Why the Gut Lining Heals So Fast

The gut lining has one of the fastest turnover rates of any tissue in the body. Stem cells at the base of each crypt divide continuously, and their daughter cells migrate up towards the tips of the villi over a few days before being shed. After injury, the lining first closes small gaps by a process called restitution, in which surviving cells at the edge of the wound flatten and slide across to cover it, before new cells are produced to restore full thickness. Research compounds can influence any of these stages: cell migration, stem cell activity, blood supply and the inflammation that can slow everything down. Understanding which stage a compound affects is one of the main goals of gut repair research.

Inflammation and Repair: Two Sides of the Same Problem

In the gut, inflammation and repair are tightly linked. Some inflammation is necessary to clear damage and bacteria, but when it persists, it prevents healing and damages the lining further. That is why gut research so often pairs a repair-focused compound, such as BPC-157, with an inflammation-focused one, such as KPV. It is also why readouts from both sides, tissue repair and inflammatory markers, are usually measured together.

Matching the Compound to the Question

• Repair of the gut lining and ulcer models: BPC-157.
• Intestinal inflammation and NF-kappaB: KPV.
• Motility, secretion and the enteric nervous system: VIP.
• Gut movement after surgery and the ghrelin system: Ipamorelin, with GHRP-6 as a comparison.
• Antimicrobial defence of the lining: LL-37.
• Oxidative stress in the lining: Glutathione.
• Repair and inflammation together: KLOW or the Gastrointestinal Research Bundle.

Designing Gut Research With Peptides

Choose the right model

Gut research uses a range of models. Cultured intestinal cells, such as Caco-2 cells, are good for studying barrier function and transport. Chemically induced colitis models in mice, such as the DSS and TNBS models used in the KPV studies, are standard for inflammation research. Surgical models are used for motility.

Measure the right things

Useful readouts include inflammatory cytokines such as TNF-alpha and IL-6, NF-kappaB activation, tissue damage scores, barrier integrity measures such as tight junction proteins, blood vessel density, and motility measures such as transit time. Increasingly, researchers also measure the gut microbiome, as the 2022 hydrogel study did.

Think about delivery

The KPV studies show how much delivery matters in the gut: the same peptide can be given in drinking water, packaged in targeted nanoparticles or held in an inflammation-seeking gel, and each approach changes where and how it acts. BPC-157’s stability in gastric juice is itself a reason it has been studied by oral routes in animals.

Colitis Models Explained

Much of the inflammation research in this guide uses standard mouse models of colitis, and knowing how they work makes the studies easier to read.

The DSS model

Dextran sulphate sodium, or DSS, is added to drinking water, where it damages the lining of the colon and allows bacteria to trigger inflammation. It produces weight loss, bleeding and shortening of the colon over about a week. Researchers measure these signs, along with tissue damage and inflammatory markers, to see whether a compound helps. It is particularly good for studying repair of the lining.

The TNBS model

Trinitrobenzene sulphonic acid, or TNBS, is given into the colon and triggers an immune reaction against the lining, driven more by the adaptive immune system. It is often used to model aspects of Crohn’s disease.

Why use both?

Because the two models work through different mechanisms, a compound that helps in both, as KPV did in the 2008 Emory study, is more likely to be acting on a common pathway, such as NF-kappaB, rather than on something specific to one model.

Protecting the Stomach

The stomach lining is under constant chemical attack from its own acid and digestive enzymes, and from substances such as alcohol and non-steroidal anti-inflammatory drugs, which can cause ulcers. Research on how the stomach protects itself, sometimes called cytoprotection, is one of the oldest areas of gut research, and it is where BPC-157’s research began. Studies in this area measure the size of lesions, blood flow to the lining and the integrity of its mucus layer.

How Peptides Reach the Gut in Research

Gut research is unusual in that the target can be reached directly from the inside. Compounds can be given by mouth, in drinking water or by tube into the stomach; applied directly into the colon; or given systemically so they reach the gut through the blood. Each route has trade-offs: oral routes expose the peptide to digestion, while systemic routes spread it throughout the body. That is why so much effort has gone into protective delivery systems, such as the targeted nanoparticles and inflammation-seeking gels used in the KPV research, which aim to deliver the peptide exactly where the inflammation is.

The Technical Breakdown: How Peptides Act in the Gut

This section goes deeper for readers who want the biology.

PepT1

PepT1 is a proton-coupled transporter on the surface of intestinal cells that absorbs di- and tripeptides produced by digestion. It is not very selective, which is why it can carry small research peptides such as KPV. It is abundant in the small intestine and normally scarce in the colon, but becomes more active in the colon during chronic inflammation.

NF-kappaB

NF-kappaB is a transcription factor held inactive in the cytoplasm until an inflammatory signal frees it to enter the nucleus and switch on inflammatory genes. Because it sits at the hub of so many inflammatory pathways, inhibiting its activation can dampen inflammation broadly.

VIP receptors

VIP acts through two G protein-coupled receptors, VPAC1 and VPAC2, which raise cyclic AMP inside cells. In smooth muscle this causes relaxation; in immune cells it tends to shift responses away from inflammation; in the gut lining it drives secretion.

Tight junctions

Tight junctions are protein complexes that seal the gaps between gut lining cells. Proteins such as occludin, claudins and ZO-1 form the seal, and their levels are common readouts of barrier health in gut research.

Why Quality Matters in Gut Research

Gut research often compares closely related compounds and measures subtle changes in inflammation and barrier function. Short peptides such as KPV depend on sequence-specific effects, and contamination with related dipeptides could confuse results. Longer peptides such as BPC-157 and VIP require accurate synthesis across many coupling steps.

Every compound supplied by Crown Peptides comes with a batch-specific certificate of analysis showing HPLC purity and mass spectrometry identity. Published certificates are on our Lab Reports page, and our guides to peptide testing, reading a certificate of analysis and reconstitution cover the practical side. Bacteriostatic Water is available alongside.

Related Compounds and Where to Go Next

Browse the full gastrointestinal research peptides category. For the immune side of gut research, see our immune research guide, and for tissue repair more broadly, best peptides for recovery research.

Gut Research Questions, Answered

Which peptide is most studied for the gut?

BPC-157 has one of the largest bodies of gastrointestinal research in animal models, and was reviewed by a US FDA advisory committee in 2026 for ulcerative colitis. KPV has the most detailed mechanistic research on intestinal inflammation.

Why does BPC-157 survive the stomach?

It is derived from a protein found in gastric juice and is unusually resistant to breakdown in acidic conditions, which is why it is called the stable gastric pentadecapeptide.

How does KPV get into gut cells?

Research has shown it is carried in by PepT1, the transporter the gut uses to absorb small peptides from food.

What is VIP?

Vasoactive intestinal peptide, a 28-amino-acid neuropeptide that regulates gut movement, secretion, blood flow and immune responses.

Can gut research peptides be combined?

Yes. Pairing a repair-focused compound such as BPC-157 with an inflammation-focused one such as KPV is common, and the Gastrointestinal Research Bundle and KLOW both bring several gut-relevant compounds together.

What is PepT1?

The transporter the gut uses to absorb small peptides from digested food. Research has shown that KPV enters gut cells through it, and that it becomes more active in the inflamed colon.

Is there a single best peptide for gut research?

No. The right choice depends on the question. BPC-157 fits studies of repair and blood vessel growth in the lining, KPV fits studies of inflammatory signalling, VIP fits studies of motility, secretion and immune regulation, and ghrelin receptor agonists fit studies of gut movement. Combining a repair-focused compound with an inflammation-focused one is a common and informative design, because in the gut the two processes are so closely linked.

Why does gut research so often use mice?

Because well-established mouse models of colitis and gut injury allow researchers to measure inflammation, tissue damage and repair in a living system, with the whole immune system and microbiome present.

What was the first hormone ever discovered?

Secretin, a gut peptide, discovered in 1902 by William Bayliss and Ernest Starling. It tells the pancreas to release digestive juice.

What is the gut-brain axis?

The two-way communication between the gut and the brain through nerves, hormones and immune signals. Many gut peptides, including VIP and ghrelin, also act in the brain.

Are gut research peptides legal in the UK?

None of the peptides in this guide is a controlled drug in the UK. See are peptides legal in the UK.

The Gut’s Own Language

The gut has always been a peptide organ: it makes them, absorbs them and depends on them to balance repair, defence and movement. The research peptides in this guide each tap into that system from a different direction. BPC-157, born in gastric juice, is studied for repairing the lining. KPV rides the gut’s own transporter to calm inflammation from within. VIP is the gut’s native regulator of movement and immunity. Ghrelin receptor agonists get a stalled gut moving again. Together, they make the gut one of the most rewarding areas in peptide research.

Explore the Gastrointestinal Research Bundle and the wider gastrointestinal research range from Crown Peptides, every batch HPLC and mass spectrometry verified and dispatched from the UK.